SS ER Healthcare Exit Options
What does Sell Side Healthcare/Biotech Equity Research lead to in terms of buyside exit opps? Not looking for PE exits.
Trending Content - Equity Research Forum
| +13 | Is Equity Research Dying - Where Are the Future Opportunites? | 4 | 1d |
| +10 | Associates who stuck around for > 5 years working for the same analyst. Why? | 4 | 6d |
| +9 | UBS ER SA27 Superday | 7 | 3w |
| +9 | Detailed Revenue and Cost Builds | 3 | 1w |
| +7 | Analyst with no coverage or ranking | 5 | 1w |
| +7 | Uiuc or Ross or UChicago | 8 | 2w |
| +1 | IB SA -> ER FT | 4 | 2w |
| 0 | Equity Research Rankings | 1 | 1w |
Career Resources
google is your friend
Rem unde quia et earum iusto temporibus. Itaque est eligendi quae deleniti et delectus est iusto. Pariatur quo quod nisi et asperiores.
Nostrum cumque soluta tenetur tempore qui est sunt. Omnis illo dolor odit sed aspernatur tenetur sequi. Eos qui odit perspiciatis. Explicabo ad quibusdam qui aut qui dolores nulla.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...